Market Overview

Puma Biotechnology +4.6%@ Premarket @ $85.75; Co Announced Positive PB272 Phase 2 Data From TBCRC 022 Trial on Saturday at #ASCO17

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Pre-Market Outlook Movers

 

Related Articles (PBYI)

Partner Center